Suchergebnisse - "Fobare, Sydney"

PubPharm (9)

1

Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia

enthalten in: JCI insight | 2024

von Elgamal, O. | Fobare, S. | Vibhute, S. | +30

2

Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia

enthalten in: Cancers | 2024

von Fobare, S. | Elgamal, O. | Wunderlich, M. | +13

3

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia : Alliance for Clinical Trials in Oncology study

enthalten in: Blood advances | 2023

von Bhatnagar, B. | Kohlschmidt, J. | Orwick, S. | +14

4

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

enthalten in: Cancers | 2022

von Eisenmann, E. | Stromatt, J. | Fobare, S. | +10

5

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia

enthalten in: Blood advances | 2022

von Fobare, S. | Kohlschmidt, J. | Ozer, H. | +15

6

Preclinical Characterization of TP‐0903, a Novel Multikinase Inhibitor, in TP53 Mutant Acute Myeloid Leukemia

enthalten in: The FASEB Journal | 2021

von Eisenmann, E. | Fobare, S. | Huang, K. | +10

7

Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress

enthalten in: Toxicology in vitro : an international journal published in association with BIBRA | 2019

von Caro, A. | Davis, A. | Fobare, S. | +3

8

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia

enthalten in: Oncotarget | 2017

von Miller, C. | Ruppert, A. | Fobare, S. | +14

9

Abstract 4520: The effect of EPZ011989, an enhancer of Zeste homolog 2 inhibitor, in acute myeloid leukemia

enthalten in: Cancer research | 2016

von Fobare, S. | Miller, C. | Orwick, S. | +3

1
[1]